Logo

American Heart Association

  2
  0


Final ID:

Panelist 4

  • Kadian, Daniella  ( Mount Sinai Hospital , New York , New York , United States )
  • Leleiko, Rebecca  ( Emory University School of Medicine , Atlanta , Georgia , United States )
  • Author Disclosures:
    Daniella Kadian: DO have relevant financial relationships ; Consultant:Boston Scientific:Active (exists now) ; Speaker:Medscape:Active (exists now) ; Speaker:Women As One:Past (completed) ; Executive Role:Society for Vascular Medicine:Active (exists now) ; Executive Role:CLI Global Society:Active (exists now) ; Research Funding (PI or named investigator):Philips Healthcare:Past (completed) ; Speaker:Abbott Laboratories:Active (exists now) | Rebecca LeLeiko: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

More abstracts on this topic:
Panelist 2

Leon Katherine, Treat-jacobson Diane

Panelist 3

Baird Ali

More abstracts from these authors:
Genetics of FMD and SCAD: Where we are and where we need to go

Kovacic Jason, Saw Jacqueline, Ganesh Santhi, Kadian Daniella

Discussant: ONCO PE Trial

Kadian Daniella, Casanegra Ana, Okwuosa Tochi

You have to be authorized to contact abstract author. Please, Login
Not Available